306 related articles for article (PubMed ID: 24561222)
1. Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats.
Yabuki Y; Shioda N; Maeda T; Hiraide S; Togashi H; Fukunaga K
Brain Res; 2014 Apr; 1557():90-100. PubMed ID: 24561222
[TBL] [Abstract][Full Text] [Related]
2. Decreased CaMKII and PKC activities in specific brain regions are associated with cognitive impairment in neonatal ventral hippocampus-lesioned rats.
Yabuki Y; Nakagawasai O; Moriguchi S; Shioda N; Onogi H; Tan-No K; Tadano T; Fukunaga K
Neuroscience; 2013 Mar; 234():103-15. PubMed ID: 23313709
[TBL] [Abstract][Full Text] [Related]
3. Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.
Moriguchi S; Yamamoto Y; Ikuno T; Fukunaga K
J Neurochem; 2011 Jun; 117(5):879-91. PubMed ID: 21434925
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region.
Moriguchi S; Shioda N; Yamamoto Y; Fukunaga K
Neuroscience; 2010 Apr; 166(4):1158-66. PubMed ID: 20074623
[TBL] [Abstract][Full Text] [Related]
5. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
Ueno K; Togashi H; Yoshioka M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
[TBL] [Abstract][Full Text] [Related]
6. Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway.
Yabuki Y; Wu L; Fukunaga K
J Pharmacol Sci; 2019 Jul; 140(3):263-272. PubMed ID: 31474557
[TBL] [Abstract][Full Text] [Related]
7. Novel nootropic drug sunifiram improves cognitive deficits via CaM kinase II and protein kinase C activation in olfactory bulbectomized mice.
Moriguchi S; Tanaka T; Tagashira H; Narahashi T; Fukunaga K
Behav Brain Res; 2013 Apr; 242():150-7. PubMed ID: 23295391
[TBL] [Abstract][Full Text] [Related]
8. Swimming exercise alleviates the symptoms of attention-deficit hyperactivity disorder in spontaneous hypertensive rats.
Ko IG; Kim SE; Kim TW; Ji ES; Shin MS; Kim CJ; Hong MH; Bahn GH
Mol Med Rep; 2013 Aug; 8(2):393-400. PubMed ID: 23779147
[TBL] [Abstract][Full Text] [Related]
9. Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder.
Ueno KI; Togashi H; Mori K; Matsumoto M; Ohashi S; Hoshino A; Fujita T; Saito H; Minami M; Yoshioka M
Behav Pharmacol; 2002 Feb; 13(1):1-13. PubMed ID: 11990715
[TBL] [Abstract][Full Text] [Related]
10. Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice.
Moriguchi S; Yabuki Y; Fukunaga K
J Neurochem; 2012 Feb; 120(4):541-51. PubMed ID: 22136399
[TBL] [Abstract][Full Text] [Related]
11. Impaired monoamine neural system in the mPFC of SHRSP/Ezo as an animal model of attention-deficit/hyperactivity disorder.
Suzuki N; Hiraide S; Shikanai H; Isshiki T; Yamaguchi T; Izumi T; Iizuka K
J Pharmacol Sci; 2024 Feb; 154(2):61-71. PubMed ID: 38246729
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
[TBL] [Abstract][Full Text] [Related]
13. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
[TBL] [Abstract][Full Text] [Related]
14. Ca2+/calmodulin-dependent protein kinase II and protein kinase C activities mediate extracellular glucose-regulated hippocampal synaptic efficacy.
Moriguchi S; Oomura Y; Shioda N; Han F; Hori N; Aou S; Fukunaga K
Mol Cell Neurosci; 2011 Jan; 46(1):101-7. PubMed ID: 20807573
[TBL] [Abstract][Full Text] [Related]
15. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
16. Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice.
Yabuki Y; Ohizumi Y; Yokosuka A; Mimaki Y; Fukunaga K
Neuroscience; 2014 Feb; 259():126-41. PubMed ID: 24316474
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation.
Yamamoto Y; Shioda N; Han F; Moriguchi S; Nakajima A; Yokosuka A; Mimaki Y; Sashida Y; Yamakuni T; Ohizumi Y; Fukunaga K
Brain Res; 2009 Oct; 1295():218-29. PubMed ID: 19646972
[TBL] [Abstract][Full Text] [Related]
18. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
Somkuwar SS; Kantak KM; Dwoskin LP
J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
[TBL] [Abstract][Full Text] [Related]
19. Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice.
Moriguchi S; Han F; Nakagawasai O; Tadano T; Fukunaga K
J Neurochem; 2006 Apr; 97(1):22-9. PubMed ID: 16515554
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
Sarantis K; Matsokis N; Angelatou F
Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
